Sequelae of Anticoagulant Therapy in a Patient with History of Pulmonary Malignancy: A Case Report

INTRODUCTION: In patients with known malignancy and possible intracranial metastatic disease who are receiving treatment with therapeutic anticoagulation, limited data exist regarding risk of intracranial bleeding. CASE REPORT: We present a case of a 64-year-old female with known lung malignancy, ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilsdorf, Christopher B., Davis, Hillary E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676768/
https://www.ncbi.nlm.nih.gov/pubmed/33217273
http://dx.doi.org/10.5811/cpcem.2020.7.48317
Descripción
Sumario:INTRODUCTION: In patients with known malignancy and possible intracranial metastatic disease who are receiving treatment with therapeutic anticoagulation, limited data exist regarding risk of intracranial bleeding. CASE REPORT: We present a case of a 64-year-old female with known lung malignancy, evidence of possible metastatic disease, and bilateral deep vein thrombosis, who suffered severe intracranial hemorrhage following initiation of therapeutic anticoagulation. Current guidelines, available risk- stratification tools, and treatment options with their risks are discussed. CONCLUSION: In patients with known or suspected intracranial metastatic disease, clinical decision tools can assist both the clinician and the patient in weighing risks and benefits of anticoagulation.

Ejemplares similares